Large clinical trials have demonstrated their effectiveness, and they are now increasingly prescribed for diabetes and weight management
GLP1 receptor agonism ameliorates Parkinsons disease through modulation of neuronal insulin signalling and glial suppression [preprint]
Disclosure of interest: No disclosures E-Posters - RECOVERY, REHABILITATION AND OUTCOME 03.00 - RECOVERY, REHABILITATION AND OUTCOME - 03.02 - LIFE AFTER STROKE P2275 - ESOC25-1701 PREVALENCE OF RYANODINE ANTIBODIES IN STROKE PATIENTS WITH POST-STROKE FATIGUE (PSF): AN OBSERVATIONAL ANALYSIS Dr Karthika Pt, Vivek Nambiar 1 , Dr Sudheeran Kannoth 1 , Divyasree Chandran 1 Amrita Institute of Medical Sciences and Research Centre, Kochi, India Background and Aims: Post-stroke fatigue (PSF) is a debilitating sequela of stroke involving central and peripheral mechanisms
In rat and human tissue, high signals for GHSR1a mRNA are found expressed in several hypothalamic nuclei, the pituitary, and the dentate gyrus of the hippocampus, with additional yet reduced signals in CA2 and CA3 of the hippocampus, the substantia nigra, the ventral tegmental area, and the median raphe nuclei (Guan et al., 1997